OAR 409-030-0210
Drug Testing for Substance Abuse and Misuse
(1)
A student must undergo a drug test prior to the start date of initial placement at a covered clinical setting. Completion of a ten-panel drug test must take place prior to initial placement, but no more than three months before entry into the health profession training program requiring clinical training experience. A drug test is considered current while the student is enrolled and progressing in the health profession training program. Subsequent drug tests may not be required except for cause, or at re-entry into a program from which the student has taken more than three months of leave or has fallen out of progression. These rules do not aim to define an “acceptable” result to a drug screen. These rules ensure completion of the administrative requirements necessary for administrative clearance for students. Clinical placement settings shall make all final clearance and placement decisions.(2)
At a minimum, a covered student seeking a clinical placement at a covered clinical site must undergo a standard 10-panel drug test and must sign any necessary authorizations. Screens for the following eight substances must be included in the 10-panel drug screen:(a)
Amphetamines (including methamphetamines);(b)
Barbiturates;(c)
Benzodiazepines;(d)
Cocaine;(e)
Marijuana;(f)
Methadone;(g)
Opiates; and(h)
Phencyclidine.(3)
All drug testing must be conducted by a laboratory licensed and operated in accordance with ORS 438.010 (Definitions for ORS 438.010 to 438.510) and OAR 333-024-0305 (Testing for Substances of Abuse: Purpose and Scope) through 333-024-0350 (Testing for Substances of Abuse: Equipment and Facilities). The health profession program must verify that screening is performed by a reputable vendor.
Source:
Rule 409-030-0210 — Drug Testing for Substance Abuse and Misuse, https://secure.sos.state.or.us/oard/view.action?ruleNumber=409-030-0210.